Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 1500/11 AM ET

Tue, 08th May 2018 16:23

Editor: Steve Orlofsky +1 646 223 6200

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Japan's Takeda clinches $62 bln deal to buy drugmaker Shire

LONDON/TOKYO - Takeda Pharmaceutical agrees to buyLondon-listed Shire for $61.50 billion, marking the biggest dealyet in a wave of transactions sweeping the drug industry.(SHIRE-M&A/TAKEDA (UPDATE 5, PIX, TV), moved, by Ben Hirschler,Paul Sandle and Sam Nussey, 1,000 words)

EXCLUSIVE-Comcast prepares all-cash bid to gate-crashDisney-Fox deal

U.S. cable operator Comcast Corp is asking investment banksto increase a bridge financing facility by as much as $60billion so it can make an all-cash offer for the media assetsthat Twenty-First Century Fox Inc has agreed to sell to WaltDisney Co for $52 billion, three people familiar with the mattersay. (FOX-M&A/COMCAST (EXCLUSIVE, UPDATE 3, PIX, TV), moved, byGreg Roumeliotis and Liana B. Baker, 550 words)

+ See also:

- SKY-M&A/COMCAST, moved, 510 words

- FOX-M&A/COMCAST/ (UPDATE 1), moving shortly, by ArjunPanchadar and Sonam Rai, 390 words)

EXCLUSIVE-Walmart's grocery delivery partnerships with Uber,Lyft fail to take off

Walmart Inc's online grocery delivery partnerships withride-hailing services Uber and Lyft have ended, according to twosources, a potential setback for the retailer's ambitions tochallenge Amazon.com Inc head-on with speedy delivery ofgroceries to people's homes. (WALMART-GROCERY/DELIVERY(EXCLUSIVE, TV, PIX), moved, by Nandita Bose and HeatherSomerville, 900 words)

Fed debates new vocabulary as it shifts away from loosepolicies

PALO ALTO, Calif./AMELIA ISLAND, Fla. - The Federal Reserveis entering new terrain in its post-crisis planning: how todescribe the conditions under which it would try to slow theeconomy and to do so without alarming financial markets.(USA-FED/ (PIX, GRAPHIC), moving shortly, by Ann Saphir andHoward Schneider, 750 words)

EXPLAINER-Strikes and a departing CEO: Turmoil at AirFrance-KLM

BERLIN - Reuters looks at the major issues that underlie theturmoil at Franco-Dutch airline Air France-KLM its CEOsaid he would resign following the rejection of a pay offer bystriking French staff. (AIR FRANCE KLM-DISPUTE/ (EXPLAINER),moved, 680 words)

MARKETS

Wall St lower, Trump's Iran decision awaited

U.S. stocks edge lower, pulled down by technology andconsumer discretionary stocks, while investors await PresidentDonald Trump's decision on the Iran nuclear deal. (USA-STOCKS/(UPDATE 2), updated throughout the day, 420 words)

+ See also:

- GLOBAL-MARKETS/ (WRAPUP 5), updated throughout the day,710 words

Hedge funds slash bearish dollar bets, and there's more tocome: McGeever

LONDON - Hedge funds and speculators spent the first fourmonths of the year betting heavily against the dollar. They'renow running for the hills. (GLOBAL-MARKETS/SPECULATORS(COLUMN), moved, by Jamie McGeever, 560 words)

ENERGY

Oil backs off 2014 highs ahead of Trump's decision on Iran

LONDON - Oil eases ahead of an announcement by U.S.President Donald Trump later in the day on whether the UnitedStates will reimpose sanctions on Iran, but the price holdswithin sight of its highest in more than three years.(GLOBAL-OIL/ (UPDATE 5), updated throughout the day, 390 words)

Trump to lay out biofuels plan in meeting with senators-sources

U.S. President Donald Trump is expected to lay out his plansfor the nation's biofuel policy on Tuesday in a closed doorbriefing with senators, after months of hearing arguments aboutthe hotly contested regulation, according to two sources.(USA-BIOFUELS/TRUMP (PIX), moved, by Jarrett Renshaw, 540 words)

Andeavor says it saved $100 mln in U.S. biofuel costs in2016-17

NEW YORK - Andeavor, one of the largest U.S. refiningcompanies, has reported saving $100 million over the past twoyears because of lower compliance costs related to the U.S.Renewable Fuel Standard, which requires refiners to mix biofuelslike ethanol into the nation's fuel or purchase credits fromrivals that do. (USA-BIOFUELS/SAVINGS, moved, by JarrettRenshaw, 370 words)

ECONOMY

'Upswing remains intact': German data dispels downswingconcerns

BERLIN - A stronger-than-expected rebound in Germanindustrial output in March, and a jump in exports in the samemonth, help ease concerns that growth in Europe's biggesteconomy could have come to a standstill at the start of theyear. (GERMANY-ECONOMY/INDUSTRIALOUTPUT (UPDATE 3), moved, byMichael Nienaber, 670 words)

China April exports bounced back more than expected despiteUS trade brawl

BEIJING - China's exports rebounded more strongly thanexpected in April after a surprise drop the previous month,suggesting global demand remains relatively resilient andproviding a cushion to the economy amid a heated trade disputewith the United States. (CHINA-ECONOMY/TRADE (UPDATE 2, PIX,GRAPHIC), moved, by Elias Glenn, 790 words)

+ See also:

- USA-TRADE/CHINA-TALKS (UPDATE 1), moved, 360 words

Drab data show Bank of England's Carney a 'sensitiveboyfriend'

LONDON - Signals that Britain's economy is slowing suggest"unreliable boyfriend" Mark Carney - whose recent commentsup-ended expectations the Bank of England would raise rates thismonth - may just be in touch with his data-sensitive side.(BRITAIN-ECONOMY/ (GRAPHIC, PIX), moved, by Andy Bruce, 640words)

TRADE

US says something 'terribly wrong' at WTO, attacks China

GENEVA - The new U.S. ambassador to the World TradeOrganization tells the WTO's membership that something has gone"terribly wrong" with judges at the world body and that China'sarguments showed Beijing is living in a fantasy. (USA-TRADE/WTO(UPDATE 1), moved, by Tom Miles, 460 words)

COMPANIES

Valeant Pharma to rename itself as Bausch Health, liftsrevenue outlook

Valeant Pharmaceuticals International Inc has decided totake the name of its best performing optical products unit,Bausch Health Companies Inc, as part of a turnaround plan andraises its 2018 revenue forecast. (VALEANT PHARM IN-RESULTS/(UPDATE 2), moved, 290 words)

Icahn, Deason want bid of at least $40 per share for Xerox

Carl Icahn and Darwin Deason, shareholders in Xerox Corp whooppose an agreed deal with Fujifilm Holdings, say they wouldconsider an all-cash bid of at least $40 per share - a 43percent premium to the Japanese firm's offer.(XEROX-M&A/FUJIFILM (UPDATE 6, PIX), moved, by LahareeChatterjee, 620 words)

Walmart likely to announce Flipkart deal before end of thisweek -sources

MUMBAI/BENGALURU - Walmart is likely to announce itsmuch-anticipated deal to buy a controlling stake in Indiane-commerce player Flipkart before the end of this week, twosources said, in what is likely to be the U.S. retail giant'sbiggest acquisition of a business. (FLIPKART-M&A/WALMART (PIX),moved, by Sankalp Phartiyal and Nivedita Bhattacharjee, 460words)

EXCLUSIVE-Hudson's Bay seeks to revive Lord & Taylor'sfortunes

Hudson's Bay Co is working with investment bankers andconsultants to identify deals and new measures to turn aroundits Lord & Taylor department store chain, once the cornerstoneof its retail empire, people familiar with the matter say.(HUDSONSBAY-LORD&TAYLOR/ (UPDATE 1, EXCLUSIVE, PIX, GRAPHIC),moved, by Jessica DiNapoli and Nichola Saminather, 970 words)

ALSO IN THE NEWS

Lack of Wall St back-office deters mainstream cryptoinvestments

NEW YORK - Mundane back-office concerns are giving pause topotential investors in digital currency hedge funds who haveotherwise warmed up to the volatile asset class.(CRYPTO-CURRENCIES/FUNDS (PIX), moved, by Lawrence Delevingneand Anna Irrera, 860 words)

Memory boost: How chipmakers are weathering slowingsmartphone sales

SEOUL/SINGAPORE - Investors in global chipmakers have had arocky ride in the last few months on worries about a slowingsmartphone market, but a clamor for more video content fromconsumers is underpinning sales for memory-chip makers.(TECH-CHIPS/ (ANALYSIS, PIX), moved, by Joyce Lee and SayantaniGhosh, 750 words)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.